The median OS of MDS patients with high PIWIL2 levels was 23.5 months, whereas the OS of patients with low PIWIL2 was 64.7 months (HR = 2.934, 95% CI = 1.5675.493, p = 0.0002). Here, PIWIL2 is linked to myelodysplastic syndrome.